Gland Pharma Ltd Company Profile
✉ Email this page to a colleague
What is the competitive landscape for GLAND PHARMA LTD, and what generic and branded alternatives to GLAND PHARMA LTD drugs are available?
GLAND PHARMA LTD has one hundred and twelve approved drugs.
There are two tentative approvals on GLAND PHARMA LTD drugs.
Summary for Gland Pharma Ltd
US Patents: | 0 |
Tradenames: | 102 |
Ingredients: | 97 |
NDAs: | 112 |
Drug Master File Entries: | 37 |
Drugs and US Patents for Gland Pharma Ltd
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gland Pharma Ltd | ARGATROBAN | argatroban | INJECTABLE;INJECTION | 217848-001 | Jul 31, 2023 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Gland Pharma Ltd | DIPHENHYDRAMINE HYDROCHLORIDE | diphenhydramine hydrochloride | INJECTABLE;INJECTION | 218448-001 | Mar 20, 2024 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Gland Pharma Ltd | MELPHALAN HYDROCHLORIDE | melphalan hydrochloride | INJECTABLE;INJECTION | 209826-001 | May 28, 2019 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Gland Pharma Ltd | PLERIXAFOR | plerixafor | SOLUTION;SUBCUTANEOUS | 206644-001 | May 3, 2024 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Gland Pharma Ltd | MAGNESIUM SULFATE IN PLASTIC CONTAINER | magnesium sulfate | INJECTABLE;INJECTION | 213917-001 | Jul 10, 2020 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Gland Pharma Ltd | FOMEPIZOLE | fomepizole | INJECTABLE;INJECTION | 216791-001 | Jul 6, 2023 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Gland Pharma Ltd | CARBOPROST TROMETHAMINE | carboprost tromethamine | INJECTABLE;INJECTION | 217657-001 | Aug 7, 2023 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for GLAND PHARMA LTD drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Injection | 100 mg/mL, 2.5 mL vials | ➤ Subscribe | 2007-09-24 |
➤ Subscribe | Injection | 250 mcg/0.5 mL, 1 mL PFS | ➤ Subscribe | 2012-03-30 |
➤ Subscribe | Injection | 1 mg/mL, 50 mL vials | ➤ Subscribe | 2011-12-16 |
Similar Applicant Names
Here is a list of applicants with similar names.